ASTONEALAB logo

Astonea Labs Ltd

ASTONEALAB·BSE·
268.00 -2.00 (-0.74%)
Market Cap283.80 Cr
PE Ratio38.67
Volume46,000
Day High - Low270.00 - 257.00
52W High-Low301.30 - 118.00
DocStoX Score
5.0/10
Weak
Fair Value
Sign in to see
ROE
11.95%
Average
P/E
38.67x
Expensive
Debt / Equity
0.75
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day257.00
270.00
52W118.00
301.30
DocStoX take

Supported by growth (10.0) and momentum (7.5), but held back by valuation (1.0). Growth looks strong at 10.0, but that is offset by valuation at 1.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.0
/10
Weak
Quality
Modest
ROE 12.0%
Valuation
Expensive
P/E 38.7×
Growth
Strong
Revenue +30.3% 3Y CAGR
Risk
Elevated
D/E 0.75
Momentum
Strong
82% of 52-week range

At a glance

Market Cap
₹284 Cr
52W High / Low
₹301 / ₹118
Dividend Yield
0.00%
Promoter Holding
72.30%
EPS (TTM)
₹6.93
Book Value
₹54.35

Key highlights

  • Profit compounding 65% a year
  • Revenue compounding 30% a year
  • Valuation is weak (1.0/10)
  • Small ₹284 cr company — thinner liquidity
2 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Astonea Labs Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.